DD295848A5 - 13-brom und 13,14-dibrom-ergoline, ihre herstellung und verwendung in arzneimitteln - Google Patents

13-brom und 13,14-dibrom-ergoline, ihre herstellung und verwendung in arzneimitteln Download PDF

Info

Publication number
DD295848A5
DD295848A5 DD90344101A DD34410190A DD295848A5 DD 295848 A5 DD295848 A5 DD 295848A5 DD 90344101 A DD90344101 A DD 90344101A DD 34410190 A DD34410190 A DD 34410190A DD 295848 A5 DD295848 A5 DD 295848A5
Authority
DD
German Democratic Republic
Prior art keywords
bromo
methyl
alkyl
ergolinyl
propyl
Prior art date
Application number
DD90344101A
Other languages
German (de)
English (en)
Inventor
Gerhard Sauer
Thomas Brumby
Helmut Wachtel
Jonathan Turner
Peter A Loeschmann
Original Assignee
�����@������������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �����@������������������k�� filed Critical �����@������������������k��
Publication of DD295848A5 publication Critical patent/DD295848A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06Lysergic acid amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD90344101A 1989-09-20 1990-09-19 13-brom und 13,14-dibrom-ergoline, ihre herstellung und verwendung in arzneimitteln DD295848A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3931819A DE3931819A1 (de) 1989-09-20 1989-09-20 13-brom und 13, 14-dibrom-ergoline, ihre herstellung und verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
DD295848A5 true DD295848A5 (de) 1991-11-14

Family

ID=6390055

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90344101A DD295848A5 (de) 1989-09-20 1990-09-19 13-brom und 13,14-dibrom-ergoline, ihre herstellung und verwendung in arzneimitteln

Country Status (12)

Country Link
EP (1) EP0418990B1 (da)
JP (1) JPH03120277A (da)
AT (1) ATE97130T1 (da)
CA (1) CA2025744A1 (da)
CZ (1) CZ278319B6 (da)
DD (1) DD295848A5 (da)
DE (2) DE3931819A1 (da)
DK (1) DK0418990T3 (da)
ES (1) ES2062313T3 (da)
HU (1) HU206346B (da)
IE (1) IE65416B1 (da)
PT (1) PT95350A (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4123587A1 (de) * 1991-07-12 1993-01-14 Schering Ag 2,14-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln
US9657020B2 (en) 2015-01-20 2017-05-23 Xoc Pharmaceuticals, Inc. Ergoline compounds and uses thereof
BR112017015510A2 (pt) 2015-01-20 2018-01-30 Xoc Pharmaceuticals Inc composto de fórmula estrutural (i), método de tratamento e/ou prevenção, método de agonização do receptor d2 em um indivíduo, método de antagonização do receptor d3 em um indivíduo, método de agonização do receptor 5-ht1d em um indivíduo, método de agonização do receptor 5-ht1a em um indivíduo, método de agonização seletiva do receptor 5-ht1d em vez do receptor 5-ht1b em um indivíduo, método de agonização seletiva do re-ceptor 5-ht2c em vez do receptor 5-ht2a ou 5-ht2b em um indivíduo, método de agonização do receptor 5-ht2c em um indivíduo, método de fornecimento de atividade antagonista funcional no receptor 5-ht2b ou receptor 5-ht7, e, método de fornecimento de atividade antagonista funcional nos receptores adrenérgicos em um indivíduo
BR112019025420A2 (pt) 2017-06-01 2020-06-16 Xoc Pharmaceuticals, Inc. Compostos policíclicos e usos destes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1413068A (en) * 1972-06-22 1975-11-05 Farmaceutici Italia Bromoergolines
DE2802023A1 (de) * 1977-01-28 1978-08-03 Sandoz Ag Neue ergotderivate, ihre herstellung und verwendung
GB2074566B (en) * 1980-04-03 1983-11-02 Erba Farmitalia Ergoline derivatives
DE3533675A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-brom-ergolinderivate
DE3730124A1 (de) * 1987-09-08 1989-03-16 Eich Eckart Neue festuclavin- und pyroclavin-derivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel

Also Published As

Publication number Publication date
IE65416B1 (en) 1995-10-18
CA2025744A1 (en) 1991-03-21
ATE97130T1 (de) 1993-11-15
DE3931819A1 (de) 1991-03-28
HUT54682A (en) 1991-03-28
PT95350A (pt) 1991-05-22
CZ458290A3 (en) 1993-04-14
ES2062313T3 (es) 1994-12-16
EP0418990A3 (en) 1991-07-03
HU206346B (en) 1992-10-28
IE903369A1 (en) 1991-04-10
EP0418990B1 (de) 1993-11-10
CZ278319B6 (en) 1993-11-17
EP0418990A2 (de) 1991-03-27
DK0418990T3 (da) 1994-03-14
DE59003446D1 (de) 1993-12-16
JPH03120277A (ja) 1991-05-22

Similar Documents

Publication Publication Date Title
WO1985001048A1 (en) Aromatic esters or amides of carboxylic acid and sulfonic acid
DE3151912A1 (de) Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE19824175A1 (de) Amino-azol-Verbindungen
EP0351352B1 (de) 2-Substituierte Ergoline, ihre Herstellung und Verwendung
DE3500251C2 (de) Neue 8alpha-Acylaminoergoline
DD295848A5 (de) 13-brom und 13,14-dibrom-ergoline, ihre herstellung und verwendung in arzneimitteln
WO1993001185A1 (de) 2,14-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln
DE3413657A1 (de) Neue ergoline
EP0427827B1 (de) 8-alpha-ACYLAMINO-ERGOLINE, IHRE HERSTELLUNG UND VERWENDUNG ALS ARZNEIMITTEL
DE2509471A1 (de) Verfahren zur herstellung neuer heterocyclischer verbindungen
US5411966A (en) 2, 13-disubstituted ergolines, their production and use in pharmaceutical agents
WO1990012796A1 (de) 8β-SUBSTITUIERTE ERGOLINE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG
Stuetz et al. Ergot alkaloids. 87. New ergolines as selective dopaminergic stimulants
CH666035A5 (de) 8-alpha-acylaminoergolene.
EP0463139B1 (de) 2,13-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln
EP0213062B1 (de) 1-Alkyl-ergolinyl-thioharnstoffderivate
DE3620293A1 (de) 1-und/oder 2-substituierte ergolinderivate
DE3700825A1 (de) 8(alpha)-acylaminoergoline, ihre herstellung und verwendung
EP0217735A2 (de) Neue 2-substituierte Ergolinderivate
DE2633782A1 (de) Neue organische verbindungen, ihre herstellung und verwendung
DE4333287A1 (de) Fluorierte Ergoline
DE3941967A1 (de) Neue phosphor- und phosphorigsaeureamide von ergolinen
DE3544365A1 (de) 8(alpha)-acylaminoergoline
AT392640B (de) Verfahren zur herstellung von neuen 8alpha-acylaminoergolinen
EP0429153A1 (de) Neue Agroclavin- und Elymoclavin-Derivate, Verfahren zu deren Herstellung und deren Verwendung in Arzneimitteln

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee